Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy
Neurology
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy?
There are 1 clinical trial targeting Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy tracked by BioSniper.
What is the prevalence of Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy?
The estimated prevalence of Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy is approximately 30.0 per 100,000 population.
Deep-dive into Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis